Strides Arcolab gains on receiving US FDA approval status for Oral Dosage Facility at Bangalore

30 Jan 2015 Evaluate

Strides Arcolab is currently trading at Rs. 926.65, up by 25.65 points or 2.85 % from its previous closing of Rs. 901.00 on the BSE.

The scrip opened at Rs. 905.45 and has touched a high and low of Rs. 941.70 and Rs. 898.00 respectively. So far 86283 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 999.00 on 05-Dec-2014 and a 52 week low of Rs. 343.80 on 26-Feb-2014.

Last one week high and low of the scrip stood at Rs. 936.00 and Rs. 885.80 respectively. The current market cap of the company is Rs. 5562.24 crore.

The promoters holding in the company stood at 27.67 % while Institutions and Non-Institutions held 46.39 % and 25.93 % respectively.

Strides Arcolab's Oral Dosage Facility (KRS Gardens) at Bangalore has been found acceptable by the United States Food and Drug Administration (US FDA). The inspection was carried out in August 2014.

The Oral Dosage facility in Bangalore manufactures oral dosage forms such as tablets, capsules (both hard gelatine and soft gelatine) and sachets. The manufacturing plant supports important current and future submissions for the US Market.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

 

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×